A Study of Lasmiditan in Healthy Participants When Co-administered With Topiramate

NCT03308669 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Lasmiditan
DRUG: Placebo
DRUG: Topiramate

Sponsor

Eli Lilly and Company